170 related articles for article (PubMed ID: 23369168)
1. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
Maratea D; Fadda V; Trippoli S; Messori A
Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
[No Abstract] [Full Text] [Related]
2. Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
Hadziyannis SJ
Aliment Pharmacol Ther; 2012 Jun; 35(12):1482. PubMed ID: 22582839
[No Abstract] [Full Text] [Related]
3. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Benhamou Y
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
[No Abstract] [Full Text] [Related]
4. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
[TBL] [Abstract][Full Text] [Related]
5. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir?
Sadler MD; Lee SS
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339. PubMed ID: 24803253
[No Abstract] [Full Text] [Related]
6. Letter: Treatment of HBeAg+ chronic hepatitis B--is tenofovir truly superior to entecavir? Authors' reply.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 Jun; 39(11):1339-40. PubMed ID: 24803254
[No Abstract] [Full Text] [Related]
7. Comparison of the efficacy of entecavir and tenofovir in chronic hepatitis B.
Güzelbulut F; Ovünç AO; Oetinkaya ZA; Senates E; Gökden Y; Saltürk AG; Sezikli M; Ozkara S; Cetinkaya F
Hepatogastroenterology; 2012; 59(114):477-80. PubMed ID: 21940383
[TBL] [Abstract][Full Text] [Related]
8. Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.
Ong A; Wong VW; Wong GL; Chan HY; Tse CH; Chan HL
Aliment Pharmacol Ther; 2011 Oct; 34(8):972-81. PubMed ID: 21883327
[TBL] [Abstract][Full Text] [Related]
9. [Drug approval studies of Viread. As effective in HBeAg positive as also in HBeAg negative patients].
MMW Fortschr Med; 2008 May; 150(21):43. PubMed ID: 18578068
[No Abstract] [Full Text] [Related]
10. [Comparison of efficacy between adefovir dipivoxil and entecavir in patients with chronic hepatitis B].
Yang F; Wu XF; Wei N
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):65-6. PubMed ID: 20128975
[No Abstract] [Full Text] [Related]
11. Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Reijnders JG; Janssen HL
J Hepatol; 2008 Mar; 48(3):383-6. PubMed ID: 18191272
[No Abstract] [Full Text] [Related]
12. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients.
Bradshaw D; Danta M
Aliment Pharmacol Ther; 2014 May; 39(9):992. PubMed ID: 24689343
[No Abstract] [Full Text] [Related]
13. [Improvement of health-related quality of life in chronic hepatitis B patients treated with entecavir or adefovir].
Yu JH; Li Q; Yang X; Fan WB; Xie SS; Li WW; Liu L; Chen SJ
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):305-6. PubMed ID: 21805739
[No Abstract] [Full Text] [Related]
14. Commentary: tenofovir is superior to entecavir in HBeAg-positive chronic hepatitis B patients--authors' reply.
Gao L; Trinh HN; Li J; Nguyen MH
Aliment Pharmacol Ther; 2014 May; 39(9):993. PubMed ID: 24689344
[No Abstract] [Full Text] [Related]
15. Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.
Singal AK; Salameh H; Kuo YF; Fontana RJ
Aliment Pharmacol Ther; 2013 Jul; 38(2):98-106. PubMed ID: 23713520
[TBL] [Abstract][Full Text] [Related]
16. [New option for successful therapy of chronic hepatitis B].
Ortleb J
Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1565. PubMed ID: 12899163
[No Abstract] [Full Text] [Related]
17. New nucleoside analogues for chronic hepatitis B.
Schalm SW; Wolters LM; van Nunen AB; Niesters HG; de Man RA
Acta Gastroenterol Belg; 2000; 63(2):191-3. PubMed ID: 10925461
[No Abstract] [Full Text] [Related]
18. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.
Mohamadnejad M
Arch Iran Med; 2006 Jan; 9(1):90-2. PubMed ID: 16649389
[No Abstract] [Full Text] [Related]
19. [Treatment of chronic hepatitis B. High response rate in general practice].
Einecke D
MMW Fortschr Med; 2010 Jul; 152(28-30):22. PubMed ID: 20848981
[No Abstract] [Full Text] [Related]
20. Long-term results of treatment with nucleoside and nucleotide analogues (entecavir and tenofovir) for chronic hepatitis B.
Asselah T; Marcellin P
Clin Liver Dis; 2013 Aug; 17(3):445-50. PubMed ID: 23905815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]